Camber Spine Technologies received FDA 510(k) clearance for the Siconus™ SI Joint Fixation System for the treatment of sacroiliac disease, as a complement to Prolix™ custom-machined allograft.
Siconus was developed under a collaborative agreement with the Institute for Musculoskeletal Science & Education.
Camber Spine received its first 510(K) in 1H13, for the TLS 5.0 Interbody Cage. Most recently (early 3Q16), the company announced the first implantation of the ENZA™ MIS Zero-Profile anterior lumbar interbody fusion device, occurring in a 2-level lumbar procedure.
Sources:Â Camber Spine Technologies, LLP; cambermedtech.com; ORTHOWORLD Inc.
Camber Spine Technologies received FDA 510(k) clearance for the Siconus™ SI Joint Fixation System for the treatment of sacroiliac disease, as a complement to Prolix™ custom-machined allograft.
Siconus was developed under a collaborative agreement with the Institute for Musculoskeletal Science & Education.
Camber Spine received its...
Camber Spine Technologies received FDA 510(k) clearance for the Siconus™ SI Joint Fixation System for the treatment of sacroiliac disease, as a complement to Prolix™ custom-machined allograft.
Siconus was developed under a collaborative agreement with the Institute for Musculoskeletal Science & Education.
Camber Spine received its first 510(K) in 1H13, for the TLS 5.0 Interbody Cage. Most recently (early 3Q16), the company announced the first implantation of the ENZA™ MIS Zero-Profile anterior lumbar interbody fusion device, occurring in a 2-level lumbar procedure.
Sources:Â Camber Spine Technologies, LLP; cambermedtech.com; ORTHOWORLD Inc.
You are out of free articles for this month
Subscribe as a Guest for $0 and unlock a total of 5 articles per month.
You are out of five articles for this month
Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.
JV
Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.